カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のPD-L1阻害剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global PD-L1 Inhibitors Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	■ 発行会社/調査会社：GlobalInfoResearch ■ 商品コード：GIR22NO19516 ■ 発行日：2022年11月（※2025年版があります。お問い合わせください。） ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：73 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（注文後2-3日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のPD-L1阻害剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

PD-L1阻害剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のPD-L1阻害剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

PD-L1阻害剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・テセントリク、インフィンジ、バベンシオ

用途別セグメントは次のように区分されます。
・小売薬局、病院薬局、その他

世界のPD-L1阻害剤市場の主要な市場プレーヤーは以下のとおりです。
・Roche、AstraZeneca、Merck KGaA

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、PD-L1阻害剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なPD-L1阻害剤メーカーの企業概要、2019年～2022年までのPD-L1阻害剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なPD-L1阻害剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別PD-L1阻害剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのPD-L1阻害剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのPD-L1阻害剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびPD-L1阻害剤の産業チェーンを掲載しています。
・第13、14、15章では、PD-L1阻害剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- PD-L1阻害剤の概要
- 種類別分析（2017年vs2021年vs2028年）：テセントリク、インフィンジ、バベンシオ
- 用途別分析（2017年vs2021年vs2028年）：小売薬局、病院薬局、その他
- 世界のPD-L1阻害剤市場規模・予測
- 世界のPD-L1阻害剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Roche、AstraZeneca、Merck KGaA
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：テセントリク、インフィンジ、バベンシオ
・用途別分析2017年-2028年：小売薬局、病院薬局、その他
・PD-L1阻害剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・PD-L1阻害剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・PD-L1阻害剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・PD-L1阻害剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・PD-L1阻害剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The PD-L1 Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global PD-L1 Inhibitors market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Retail Pharmacy accounting for % of the PD-L1 Inhibitors global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While TECENTRIQ segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of PD-L1 Inhibitors include Roche, AstraZeneca, Merck KGaA, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
PD-L1 Inhibitors market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
TECENTRIQ
Imfinzi
Bavencio
Market segment by Application can be divided into
Retail Pharmacy
Hospital Pharmacy
Other
The key market players for global PD-L1 Inhibitors market are listed below:
Roche
AstraZeneca
Merck KGaA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PD-L1 Inhibitors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of PD-L1 Inhibitors, with price, sales, revenue and global market share of PD-L1 Inhibitors from 2019 to 2022.
Chapter 3, the PD-L1 Inhibitors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-L1 Inhibitors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and PD-L1 Inhibitors market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PD-L1 Inhibitors.
Chapter 13, 14, and 15, to describe PD-L1 Inhibitors sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 PD-L1 Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global PD-L1 Inhibitors Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 TECENTRIQ
1.2.3 Imfinzi
1.2.4 Bavencio
1.3 Market Analysis by Application
1.3.1 Overview: Global PD-L1 Inhibitors Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global PD-L1 Inhibitors Market Size & Forecast
1.4.1 Global PD-L1 Inhibitors Sales in Value (2017 & 2021 & 2028)
1.4.2 Global PD-L1 Inhibitors Sales in Volume (2017-2028)
1.4.3 Global PD-L1 Inhibitors Price (2017-2028)
1.5 Global PD-L1 Inhibitors Production Capacity Analysis
1.5.1 Global PD-L1 Inhibitors Total Production Capacity (2017-2028)
1.5.2 Global PD-L1 Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 PD-L1 Inhibitors Market Drivers
1.6.2 PD-L1 Inhibitors Market Restraints
1.6.3 PD-L1 Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche PD-L1 Inhibitors Product and Services
2.1.4 Roche PD-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca PD-L1 Inhibitors Product and Services
2.2.4 AstraZeneca PD-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA PD-L1 Inhibitors Product and Services
2.3.4 Merck KGaA PD-L1 Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 PD-L1 Inhibitors Breakdown Data by Manufacturer
3.1 Global PD-L1 Inhibitors Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global PD-L1 Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in PD-L1 Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 PD-L1 Inhibitors Manufacturer Market Share in 2021
3.4.2 Top 6 PD-L1 Inhibitors Manufacturer Market Share in 2021
3.5 Global PD-L1 Inhibitors Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and PD-L1 Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global PD-L1 Inhibitors Market Size by Region
4.1.1 Global PD-L1 Inhibitors Sales in Volume by Region (2017-2028)
4.1.2 Global PD-L1 Inhibitors Revenue by Region (2017-2028)
4.2 North America PD-L1 Inhibitors Revenue (2017-2028)
4.3 Europe PD-L1 Inhibitors Revenue (2017-2028)
4.4 Asia-Pacific PD-L1 Inhibitors Revenue (2017-2028)
4.5 South America PD-L1 Inhibitors Revenue (2017-2028)
4.6 Middle East and Africa PD-L1 Inhibitors Revenue (2017-2028)
5 Market Segment by Type
5.1 Global PD-L1 Inhibitors Sales in Volume by Type (2017-2028)
5.2 Global PD-L1 Inhibitors Revenue by Type (2017-2028)
5.3 Global PD-L1 Inhibitors Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global PD-L1 Inhibitors Sales in Volume by Application (2017-2028)
6.2 Global PD-L1 Inhibitors Revenue by Application (2017-2028)
6.3 Global PD-L1 Inhibitors Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America PD-L1 Inhibitors Sales by Type (2017-2028)
7.2 North America PD-L1 Inhibitors Sales by Application (2017-2028)
7.3 North America PD-L1 Inhibitors Market Size by Country
7.3.1 North America PD-L1 Inhibitors Sales in Volume by Country (2017-2028)
7.3.2 North America PD-L1 Inhibitors Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe PD-L1 Inhibitors Sales by Type (2017-2028)
8.2 Europe PD-L1 Inhibitors Sales by Application (2017-2028)
8.3 Europe PD-L1 Inhibitors Market Size by Country
8.3.1 Europe PD-L1 Inhibitors Sales in Volume by Country (2017-2028)
8.3.2 Europe PD-L1 Inhibitors Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific PD-L1 Inhibitors Sales by Type (2017-2028)
9.2 Asia-Pacific PD-L1 Inhibitors Sales by Application (2017-2028)
9.3 Asia-Pacific PD-L1 Inhibitors Market Size by Region
9.3.1 Asia-Pacific PD-L1 Inhibitors Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific PD-L1 Inhibitors Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America PD-L1 Inhibitors Sales by Type (2017-2028)
10.2 South America PD-L1 Inhibitors Sales by Application (2017-2028)
10.3 South America PD-L1 Inhibitors Market Size by Country
10.3.1 South America PD-L1 Inhibitors Sales in Volume by Country (2017-2028)
10.3.2 South America PD-L1 Inhibitors Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa PD-L1 Inhibitors Sales by Type (2017-2028)
11.2 Middle East & Africa PD-L1 Inhibitors Sales by Application (2017-2028)
11.3 Middle East & Africa PD-L1 Inhibitors Market Size by Country
11.3.1 Middle East & Africa PD-L1 Inhibitors Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa PD-L1 Inhibitors Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of PD-L1 Inhibitors and Key Manufacturers
12.2 Manufacturing Costs Percentage of PD-L1 Inhibitors
12.3 PD-L1 Inhibitors Production Process
12.4 PD-L1 Inhibitors Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 PD-L1 Inhibitors Typical Distributors
13.3 PD-L1 Inhibitors Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global PD-L1 Inhibitors Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global PD-L1 Inhibitors Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche PD-L1 Inhibitors Product and Services
Table 6. Roche PD-L1 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca PD-L1 Inhibitors Product and Services
Table 10. AstraZeneca PD-L1 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 12. Merck KGaA Major Business
Table 13. Merck KGaA PD-L1 Inhibitors Product and Services
Table 14. Merck KGaA PD-L1 Inhibitors Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global PD-L1 Inhibitors Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 16. Global PD-L1 Inhibitors Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in PD-L1 Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global PD-L1 Inhibitors Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and PD-L1 Inhibitors Production Site of Key Manufacturer
Table 20. PD-L1 Inhibitors New Entrant and Capacity Expansion Plans
Table 21. PD-L1 Inhibitors Mergers & Acquisitions in the Past Five Years
Table 22. Global PD-L1 Inhibitors Sales by Region (2017-2022) & (K Units)
Table 23. Global PD-L1 Inhibitors Sales by Region (2023-2028) & (K Units)
Table 24. Global PD-L1 Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 25. Global PD-L1 Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 26. Global PD-L1 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 27. Global PD-L1 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 28. Global PD-L1 Inhibitors Revenue by Type (2017-2022) & (USD Million)
Table 29. Global PD-L1 Inhibitors Revenue by Type (2023-2028) & (USD Million)
Table 30. Global PD-L1 Inhibitors Price by Type (2017-2022) & (US$/Unit)
Table 31. Global PD-L1 Inhibitors Price by Type (2023-2028) & (US$/Unit)
Table 32. Global PD-L1 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 33. Global PD-L1 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 34. Global PD-L1 Inhibitors Revenue by Application (2017-2022) & (USD Million)
Table 35. Global PD-L1 Inhibitors Revenue by Application (2023-2028) & (USD Million)
Table 36. Global PD-L1 Inhibitors Price by Application (2017-2022) & (US$/Unit)
Table 37. Global PD-L1 Inhibitors Price by Application (2023-2028) & (US$/Unit)
Table 38. North America PD-L1 Inhibitors Sales by Country (2017-2022) & (K Units)
Table 39. North America PD-L1 Inhibitors Sales by Country (2023-2028) & (K Units)
Table 40. North America PD-L1 Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 41. North America PD-L1 Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 42. North America PD-L1 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 43. North America PD-L1 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 44. North America PD-L1 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 45. North America PD-L1 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 46. Europe PD-L1 Inhibitors Sales by Country (2017-2022) & (K Units)
Table 47. Europe PD-L1 Inhibitors Sales by Country (2023-2028) & (K Units)
Table 48. Europe PD-L1 Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe PD-L1 Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe PD-L1 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 51. Europe PD-L1 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 52. Europe PD-L1 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 53. Europe PD-L1 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 54. Asia-Pacific PD-L1 Inhibitors Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific PD-L1 Inhibitors Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific PD-L1 Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific PD-L1 Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific PD-L1 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific PD-L1 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 60. Asia-Pacific PD-L1 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 61. Asia-Pacific PD-L1 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 62. South America PD-L1 Inhibitors Sales by Country (2017-2022) & (K Units)
Table 63. South America PD-L1 Inhibitors Sales by Country (2023-2028) & (K Units)
Table 64. South America PD-L1 Inhibitors Revenue by Country (2017-2022) & (USD Million)
Table 65. South America PD-L1 Inhibitors Revenue by Country (2023-2028) & (USD Million)
Table 66. South America PD-L1 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 67. South America PD-L1 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 68. South America PD-L1 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 69. South America PD-L1 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 70. Middle East & Africa PD-L1 Inhibitors Sales by Region (2017-2022) & (K Units)
Table 71. Middle East & Africa PD-L1 Inhibitors Sales by Region (2023-2028) & (K Units)
Table 72. Middle East & Africa PD-L1 Inhibitors Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa PD-L1 Inhibitors Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa PD-L1 Inhibitors Sales by Type (2017-2022) & (K Units)
Table 75. Middle East & Africa PD-L1 Inhibitors Sales by Type (2023-2028) & (K Units)
Table 76. Middle East & Africa PD-L1 Inhibitors Sales by Application (2017-2022) & (K Units)
Table 77. Middle East & Africa PD-L1 Inhibitors Sales by Application (2023-2028) & (K Units)
Table 78. PD-L1 Inhibitors Raw Material
Table 79. Key Manufacturers of PD-L1 Inhibitors Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. PD-L1 Inhibitors Typical Distributors
Table 83. PD-L1 Inhibitors Typical Customers
List of Figures
Figure 1. PD-L1 Inhibitors Picture
Figure 2. Global PD-L1 Inhibitors Revenue Market Share by Type in 2021
Figure 3. TECENTRIQ
Figure 4. Imfinzi
Figure 5. Bavencio
Figure 6. Global PD-L1 Inhibitors Revenue Market Share by Application in 2021
Figure 7. Retail Pharmacy
Figure 8. Hospital Pharmacy
Figure 9. Other
Figure 10. Global PD-L1 Inhibitors Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global PD-L1 Inhibitors Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global PD-L1 Inhibitors Sales (2017-2028) & (K Units)
Figure 13. Global PD-L1 Inhibitors Price (2017-2028) & (US$/Unit)
Figure 14. Global PD-L1 Inhibitors Production Capacity (2017-2028) & (K Units)
Figure 15. Global PD-L1 Inhibitors Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. PD-L1 Inhibitors Market Drivers
Figure 17. PD-L1 Inhibitors Market Restraints
Figure 18. PD-L1 Inhibitors Market Trends
Figure 19. Global PD-L1 Inhibitors Sales Market Share by Manufacturer in 2021
Figure 20. Global PD-L1 Inhibitors Revenue Market Share by Manufacturer in 2021
Figure 21. PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 PD-L1 Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 PD-L1 Inhibitors Manufacturer (Revenue) Market Share in 2021
Figure 24. Global PD-L1 Inhibitors Sales Market Share by Region (2017-2028)
Figure 25. Global PD-L1 Inhibitors Revenue Market Share by Region (2017-2028)
Figure 26. North America PD-L1 Inhibitors Revenue (2017-2028) & (USD Million)
Figure 27. Europe PD-L1 Inhibitors Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific PD-L1 Inhibitors Revenue (2017-2028) & (USD Million)
Figure 29. South America PD-L1 Inhibitors Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa PD-L1 Inhibitors Revenue (2017-2028) & (USD Million)
Figure 31. Global PD-L1 Inhibitors Sales Market Share by Type (2017-2028)
Figure 32. Global PD-L1 Inhibitors Revenue Market Share by Type (2017-2028)
Figure 33. Global PD-L1 Inhibitors Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global PD-L1 Inhibitors Sales Market Share by Application (2017-2028)
Figure 35. Global PD-L1 Inhibitors Revenue Market Share by Application (2017-2028)
Figure 36. Global PD-L1 Inhibitors Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America PD-L1 Inhibitors Sales Market Share by Type (2017-2028)
Figure 38. North America PD-L1 Inhibitors Sales Market Share by Application (2017-2028)
Figure 39. North America PD-L1 Inhibitors Sales Market Share by Country (2017-2028)
Figure 40. North America PD-L1 Inhibitors Revenue Market Share by Country (2017-2028)
Figure 41. United States PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe PD-L1 Inhibitors Sales Market Share by Type (2017-2028)
Figure 45. Europe PD-L1 Inhibitors Sales Market Share by Application (2017-2028)
Figure 46. Europe PD-L1 Inhibitors Sales Market Share by Country (2017-2028)
Figure 47. Europe PD-L1 Inhibitors Revenue Market Share by Country (2017-2028)
Figure 48. Germany PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific PD-L1 Inhibitors Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific PD-L1 Inhibitors Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific PD-L1 Inhibitors Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific PD-L1 Inhibitors Revenue Market Share by Region (2017-2028)
Figure 57. China PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America PD-L1 Inhibitors Sales Market Share by Type (2017-2028)
Figure 64. South America PD-L1 Inhibitors Sales Market Share by Application (2017-2028)
Figure 65. South America PD-L1 Inhibitors Sales Market Share by Country (2017-2028)
Figure 66. South America PD-L1 Inhibitors Revenue Market Share by Country (2017-2028)
Figure 67. Brazil PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa PD-L1 Inhibitors Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa PD-L1 Inhibitors Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa PD-L1 Inhibitors Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa PD-L1 Inhibitors Revenue Market Share by Region (2017-2028)
Figure 73. Turkey PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa PD-L1 Inhibitors Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of PD-L1 Inhibitors in 2021
Figure 78. Manufacturing Process Analysis of PD-L1 Inhibitors
Figure 79. PD-L1 Inhibitors Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

世界のPD-L1阻害剤市場2022年：市場規模予測（～2028年）

グローバル市場調査会社